The up-regulation of miR-143 in prostate cancer cells represses mesenchymal markers (vimentin and fibronectin) and increases the epithelial marker E-cadherin [1], while the up-regulation of miR-145 leads to the same effects except for vimentin [1]. Here, VIM is linked to prostate cancer.